Shares of SharonAI Holdings surged 14.2% in pre-market trading to $92.49 on June 30, extending a rally that began after the company announced a landmark six-year compute agreement with Nvidia to build out AI data-center capacity in Australia. No new company announcement accompanied today's move, suggesting investors are still piling into the stock on momentum from the original catalyst — and broader enthusiasm for anything tied to AI infrastructure. SharonAI Rides Nvidia's Coattails to a 14% Pop — But With $294K in Revenue, How Long Can Momentum Outrun Reality?
Shares of SharonAI Holdings jumped another 14.2% to $92.49 in pre-market Monday with no fresh announcement, extending a rally born from the company's six-year compute partnership with Nvidia announced June 12. The move puts SHAZ well above the $79.50 mean analyst price target and raises a blunt question: can a company generating virtually no revenue today support a valuation north of $1 billion?
• The Nvidia Stamp of Approval Is Real — and Cleverly Structured. SharonAI signed a six-year deal with Nvidia to deploy 72 megawatts of new data-center capacity in Australia.
The collaboration is structured through a revenue-sharing and credit-support model , meaning SharonAI doesn't shoulder all the upfront hardware costs alone. Nvidia earns both standard product revenue and a cut of cloud revenue on the supported capacity — aligning incentives but also handing Nvidia a slice of every dollar SharonAI generates.
• The Contract Pipeline Looks Huge on Paper. SharonAI has secured a $1.25 billion five-year contract with ESDS Software Solutions and a $950 million deal with a global technology firm, contributing to a reported backlog exceeding $2.2 billion.
Revenue from these deals is expected to begin in late 2026, meaning the cash-flow impact hinges entirely on execution timing.
• Today's Financials Tell a Very Different Story. Q1 2026 revenue was just $294,000 — down 9.5% year-over-year — while costs jumped 67.7%, flipping the company to a gross loss.
Net loss ballooned to $20 million, up from $1.4 million a year ago. The company has 25 employees and only listed on Nasdaq in February. To fund the buildout, SharonAI raised $1.6 billion in June through stock, warrants, and convertible notes — diluting existing shareholders significantly.
• The Stock Is Trading on Faith, Not Fundamentals. The market is assigning a price-to-sales ratio (stock price relative to actual revenue) above 480 , extraordinary even by AI-sector standards. SHAZ is up roughly 3,900% year-to-date , and at $92.49 it sits 16% above the highest analyst target of $79.50. Widened losses, limited cash runway, and a history of heavy dilution — issuing new shares that shrink existing investors' stakes — keep financing and execution risk front and center.
The bottom line: SharonAI has landed marquee partnerships and a credible pipeline, but investors are pricing in flawless execution of a multibillion-dollar buildout by a company that barely existed 18 months ago. Any delay in converting contracts to revenue could make this rally look very fragile.